scholarly journals Shifting metaphors in direct-to-consumer genetic testing: from genes as information to genes as big data

2017 ◽  
Vol 36 (3) ◽  
pp. 296-313 ◽  
Author(s):  
Paula Saukko
Living Data ◽  
2019 ◽  
pp. 93-124
Author(s):  
Celia Roberts ◽  
Adrian Mackenzie ◽  
Maggie Mort ◽  
Theresa Atkinson ◽  
Mette Kragh-Furbo ◽  
...  

How does direct-to-consumer genetic testing alter our perceptions of health, reproduction, families and futurity? DNA genotyping is a form of biosensing concerned with genetic risks, susceptibilities and relatedness. This chapter argues that genotyping services such as 23andMe prompt us to take seriously the platform realities of biosensing. DNA genotyping platforms attempt to aggregate data on an unprecedented scale, to anchor the significance of DNA variations for health and kinship, and to connect DNA variations to health practices and health futures. The biosensors commonly used in DNA genotyping are microarrays. Their architecture and the scale of data they produce are prototypes of scientific big data. The internet platforms and products associated with direct-to-consumer DNA genotyping embody a personalizing approach to health and medicine, even though the connections between underpinning scientific findings concerning genomic variation and clinical interventions or treatments are mostly tenuous. At the same time, because the significance of the million or so variations reported in a typical DNA genotype is mostly undefined, the data has led to many attempts to create new connections, to experiment with novel collective forms of analysis and treatment, and to build new relations between biology, medicine and everyday life.


2021 ◽  
Vol 132 ◽  
pp. S289
Author(s):  
Julia Becker ◽  
Janey Youngblom ◽  
Brianne Kirkpatrick ◽  
Liane Abrams

2021 ◽  
Vol 14 (1) ◽  
Author(s):  
Masahiro Inoue ◽  
Shota Arichi ◽  
Tsuyoshi Hachiya ◽  
Anna Ohtera ◽  
Seok-Won Kim ◽  
...  

Abstract Objective In order to assess the applicability of a direct-to-consumer (DTC) genetic testing to translational research for obtaining new knowledge on relationships between drug target genes and diseases, we examined possibility of these data by associating SNPs and disease related phenotype information collected from healthy individuals. Results A total of 12,598 saliva samples were collected from the customers of commercial service for SNPs analysis and web survey were conducted to collect phenotype information. The collected dataset revealed similarity to the Japanese data but distinguished differences to other populations of all dataset of the 1000 Genomes Project. After confirmation of a well-known relationship between ALDH2 and alcohol-sensitivity, Phenome-Wide Association Study (PheWAS) was performed to find association between pre-selected drug target genes and all the phenotypes. Association was found between GRIN2B and multiple phenotypes related to depression, which is considered reliable based on previous reports on the biological function of GRIN2B protein and its relationship with depression. These results suggest possibility of using SNPs and phenotype information collected from healthy individuals as a translational research tool for drug discovery to find relationship between a gene and a disease if it is possible to extract individuals in pre-disease states by properly designed questionnaire.


2021 ◽  
pp. 1-8
Author(s):  
Janessa Mladucky ◽  
Bonnie Baty ◽  
Jeffrey Botkin ◽  
Rebecca Anderson

Introduction: Customer data from direct-to-consumer genetic testing (DTC GT) are often used for secondary purposes beyond providing the customer with test results. Objective: The goals of this study were to determine customer knowledge of secondary uses of data, to understand their perception of risks associated with these uses, and to determine the extent of customer concerns about privacy. Methods: Twenty DTC GT customers were interviewed about their experiences. The semi-structured interviews were transcribed, coded, and analyzed for common themes. Results: Most participants were aware of some secondary uses of data. All participants felt that data usage for research was acceptable, but acceptability for non-research purposes varied across participants. The majority of participants were aware of the existence of a privacy policy, but few read the majority of the privacy statement. When previously unconsidered uses of data were discussed, some participants expressed concern over privacy protections for their data. Conclusion: When exposed to new information on secondary uses of data, customers express concerns and a desire to improve consent with transparency, more opt-out options, improved readability, and more information on future uses and potential risks from direct-to-consumer companies. Effective ways to improve readership about the secondary use, risk of use, and protection of customer data should be investigated and the findings implemented by DTC companies to protect public trust in these practices.


2018 ◽  
Vol 93 (1) ◽  
pp. 113-120 ◽  
Author(s):  
Megan A. Allyse ◽  
David H. Robinson ◽  
Matthew J. Ferber ◽  
Richard R. Sharp

2015 ◽  
Vol 2 (9) ◽  
pp. 8-11
Author(s):  
Patricia Fitzpatrick Dimond

Sign in / Sign up

Export Citation Format

Share Document